Targeting Ezh2 could overcome docetaxel resistance in prostate cancer cells

被引：0
|
作者：
Xiaofu Qiu
Wei Wang
Bijun Li
Bo Cheng
Kangjian Lin
Jian Bai
Huanhui Li
Guosheng Yang
机构：
[1] Southern Medical University Third Medical College,Department of Urology
[2] Guangzhou General Hospital of Guangzhou Military Command,Department of Urology
[3] the Second Affiliated Hospital of Guangdong Medical College,Department of Urology
[4] the Affiliated Hospital of Southwest Medical University,Department of Urology
[5] Guangdong Second Provincial General Hospital,Department of Urology
来源：
BMC Cancer | / 19卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Targeting Ezh2 could overcome docetaxel resistance in prostate cancer cells
    Qiu, Xiaofu
    Wang, Wei
    Li, Bijun
    Cheng, Bo
    Lin, Kangjian
    Bai, Jian
    Li, Huanhui
    Yang, Guosheng
    BMC CANCER, 2019, 19 (1)
  • [2] Targeting EZH2 to overcome the resistance to immunotherapy in lung cancer
    Shin, Daniel Sanghoon
    Park, Kevin
    Garon, Edward
    Dubinett, Steven
    SEMINARS IN ONCOLOGY, 2022, 49 (3-4) : 306 - 318
  • [3] Targeting survivin to overcome docetaxel resistance in prostate cancer
    Peery, Robert C.
    CANCER RESEARCH, 2018, 78 (13)
  • [4] Targeting EZH2 in neuroendocrine prostate cancer
    Puca, Loredana
    Gao, Dong
    Kossai, Myriam
    Marotz, Clarisse
    Mosquera, Juan Miguel
    MacDonald, Theresa Y.
    Park, Kyung
    Rao, Rema
    Sboner, Andrea
    Chen, Yu
    Rubin, Mark A.
    Beltran, Himisha
    CANCER RESEARCH, 2015, 75
  • [5] Targeting DNA Methylation and EZH2 Activity to Overcome Melanoma Resistance to Immunotherapy
    Al Emran, Abdullah
    Chatterjee, Aniruddha
    Rodger, Euan J.
    Tiffen, Jessamy C.
    Gallagher, Stuart J.
    Eccles, Michael R.
    Hersey, Peter
    TRENDS IN IMMUNOLOGY, 2019, 40 (04) : 328 - 344
  • [6] Targeting EZH2 in cancer
    Kimberly H Kim
    Charles W M Roberts
    Nature Medicine, 2016, 22 : 128 - 134
  • [7] Targeting EZH2 in cancer
    Kim, Kimberly H.
    Roberts, Charles W. M.
    NATURE MEDICINE, 2016, 22 (02) : 128 - 134
  • [8] Targeting EZH2 to overcome the resistance to immunotherapy in microsatellite stable colorectal cancer: Results from the CAIRE study
    Palmieri, Lola Jade
    Cousin, Sophie
    Spalato, Mariella
    Guegan, Jean Philippe
    Bessede, Alban
    Pernot, Simon
    Italiano, Antoine
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [9] Targeting EZH2 in cancer therapy
    Yamagishi, Makoto
    Uchimaru, Kaoru
    CURRENT OPINION IN ONCOLOGY, 2017, 29 (05) : 375 - 381
  • [10] Nanoways to overcome docetaxel resistance in prostate cancer
    Ganju, Aditya
    Yallapu, Murali M.
    Khan, Sheema
    Behrman, Stephen W.
    Chauhan, Subhash C.
    Jaggi, Meena
    DRUG RESISTANCE UPDATES, 2014, 17 (1-2) : 13 - 23
12345